Equity Details
Price & Market Data
Price: $0.0139
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $37,811,652
Daily Volume: 0
Performance Metrics
1 Week: -44.40%
1 Month: -51.74%
3 Months: -83.65%
6 Months: -84.56%
1 Year: -94.44%
YTD: -84.47%
About Botanix Pharmaceuticals Limited (BXPHF)
Quick facts and data for Botanix Pharmaceuticals Limited (BXPHF). Price: 0.0139, daily change: $0.00 / 0.00%. Market cap: 37,811,652. Performance across all periods.
Details
Botanix Pharmaceuticals Limited operates as a commercial dermatology company in Australia and the United States. The company's lead product is Sofdra (sofpironium) topical gel, a prescription anticholinergic medicine used on the skin to treat underarm sweating in adults and children 9 years of age and older. Its product pipeline includes BTX 1503, a transdermal gel formulation for the treatment of serious acne in adults and teenagers; BTX 1801 for treating staphylococcus aureus and methicillin resistant staphylococcus aureus; BTX 1702 for the treatment of papulopustular rosacea; and BTX 1204A for treating atopic dermatitis. The company was incorporated in 1984 and is based in West Perth, Australia.